Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
23
11
2021
Statut:
ppublish
Résumé
[This corrects the article DOI: 10.1016/j.eclinm.2021.100981.].
Identifiants
pubmed: 34805808
doi: 10.1016/j.eclinm.2021.101203
pii: S2589-5370(21)00484-3
pmc: PMC8590842
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
101203Commentaires et corrections
Type : ErratumFor
Informations de copyright
© 2021 The Authors.